Johnson & Johnson JNJ earnings Q4 2020


Johnson & Johnson Coronavirus vaccine illustration

Dado Ruvic | Reuters

Johnson & Johnson on Tuesday reported fourth-quarter earnings and revenue that beat Wall Street’s expectations.

Here’s how J&J did compared with what Wall Street expected, according to average estimates compiled by Refinitiv:

  • Adjusted EPS: $1.86 per share versus $1.82 expected.
  • Revenue: $22.48 billion versus $21.67 billion expected.

“I’m incredibly proud of our Johnson & Johnson teams around the world for going above and beyond to meet stakeholder needs,” J&J CEO Alex Gorsky said in a press release. “We continue to progress our COVID-19 vaccine candidate and look forward to sharing details from our Phase 3 study…

Source cnbc.com

Xpeng rolls out autonomous driving features in challenge to Tesla

Previous article

Is Dubai’s party over? Record Covid cases spark fears of new lockdown

Next article

You may also like

Leave a Reply

Notify of

More in Earnings